
Krka
KRKG | LJSE
Overview
Corporate Details
- ISIN(s):
- SI0031102120
- LEI:
- 549300H9RLRTRTLRUZ73
- Country:
- Slovenia
- Address:
- Šmarješka cesta 006, 8501 Novo mesto
- Website:
- https://www.krka.biz/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Krka’s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products. The company's focus is on the development of high-quality own-brand generic pharmaceuticals, which offer added value, and are marketed under Krka's own brands. Our products are sold in over 70 countries. As part of our business strategy we have set the objective of balanced sales in five different regions: Slovenia, Central Europe, South-East Europe, East Europe, West Europe and Overseas Markets.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-06-06 08:30 |
Proxy Solicitation & Information Statements
Pooblastilo za glasovanje na 31. skupščini delničarjev
|
Slovene | 931.8 KB | |
2025-06-06 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Organizirano zbiranje pooblastil za uresničevanje glasovalnih pravic
|
Slovene | 2.6 KB | |
2025-05-28 08:30 |
Transaction in Own Shares
Share buy-back programme schedule from July to December 2025
|
English | 83.9 KB | |
2025-05-28 08:30 |
Transaction in Own Shares
Share buy-back programme schedule from July to December 2025
|
English | 1.6 KB | |
2025-05-28 08:30 |
Transaction in Own Shares
Terminski načrt programa odkupa lastnih delnic v drugem polletju 2025
|
English | 110.8 KB | |
2025-05-28 08:30 |
Transaction in Own Shares
Terminski načrt programa odkupa lastnih delnic v drugem polletju 2025
|
Slovene | 1.5 KB | |
2025-05-16 08:30 |
Proxy Solicitation & Information Statements
Proxy statement
|
English | 76.5 KB | |
2025-05-16 08:30 |
Registration Form
Registration form
|
English | 75.1 KB | |
2025-05-16 08:30 |
Proxy Solicitation & Information Statements
Shareholder rights
|
English | 157.8 KB | |
2025-05-16 08:30 |
Remuneration Report
Report on remuneration of management and supervisory board members 2024
|
English | 564.5 KB | |
2025-05-16 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Explanation of proposed resolutions
|
English | 240.1 KB | |
2025-05-16 08:30 |
General Meeting Notice
31 AGM notice
|
English | 218.6 KB | |
2025-05-16 08:30 |
General Meeting Notice
31st Annual General Meeting notice
|
English | 1.2 KB | |
2025-05-16 08:30 |
Interim Report
Q1 2025 Unaudited Interim Report of the Krka Group and Krka Company
|
English | 1.0 MB | |
2025-05-16 08:30 |
Earnings Release
Press release
|
English | 148.3 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
![]() |
Biogened Spolka Akcyjna | Poland | BGD | |
![]() |
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
![]() |
BOIRON | France | BOI | |
![]() |
Bonyf N.V. | Belgium | MLBON | |
![]() |
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
|
Calliditas Therapeutics | Sweden | CALTX |